Innovation and Collaboration Drive Community Oncology Forward: Christine Pfaff, RPh, MBA

Why It Matters

By marrying clinical breakthroughs with operational best practices, COA equips community oncology clinics to deliver high‑quality, cost‑effective care, a critical advantage as cancer therapies become increasingly complex and expensive.

Key Takeaways

• COA’s conference blends clinical advances with operational strategy sessions
• Practices learn to integrate new therapies into EMR and pharmacy workflows
• AI tools are showcased for clinical decision support and business efficiency
• COA facilitates peer‑to‑peer sharing on drug rollout, staffing, and payer negotiations
• Community oncology delivers coordinated, one‑stop‑shop care, improving patient experience

Pulse Analysis

The rapid emergence of novel oncology agents has outpaced many community practices’ ability to incorporate them into daily workflows. While academic centers often have dedicated teams to evaluate and adopt new regimens, community clinics must juggle limited staffing, fragmented payer contracts, and legacy technology stacks. COA’s conference addresses this gap by offering sessions that translate scientific breakthroughs into actionable operational playbooks, helping practices align treatment sequencing with real‑world constraints such as inventory management and reimbursement timelines.

Artificial intelligence is moving from hype to practical utility in community oncology. At the conference, vendors demonstrated AI‑driven platforms that flag optimal dosing, predict adverse events, and streamline prior‑authorization processes. When coupled with integrated electronic medical‑record (EMR) and pharmacy systems, these tools can reduce manual data entry, accelerate treatment initiation, and free clinicians to focus on patient interaction. The emphasis on AI underscores a broader industry trend: technology is no longer a peripheral support function but a core component of both clinical decision‑making and business efficiency.

Financial pressure remains the most persistent challenge for community oncology providers, many of whom operate on razor‑thin margins. COA’s network model facilitates peer‑to‑peer knowledge exchange, allowing clinics to benchmark staffing models, negotiate bulk purchasing agreements, and collaborate on payer strategies, including Medicare‑related reimbursement. This collaborative approach not only mitigates cost pressures but also reinforces the sector’s hallmark of coordinated, one‑stop‑shop care, ensuring patients receive seamless treatment across physicians, pharmacists, and nursing staff. As the oncology landscape continues to evolve, the blend of clinical innovation, operational agility, and collective intelligence will be essential for sustaining high‑quality care in the community setting.